Feasibility of a Coordinated Human Papillomavirus (HPV) Vaccination Program between a Medical Clinic and a Community Pharmacy

Abstract

Human papillomavirus (HPV) vaccination coverage could be enhanced by community pharmacies working with medical clinics to coordinate completion of the HPV vaccination series. The objective for this study was to assess the feasibility of a coordinated model of HPV vaccine delivery in which a clinic gives the first dose and refers patients to a partnering community pharmacy to receive subsequent doses. A medical clinic-community pharmacy team was established in a Midwestern state to develop and operate a coordinated care model for HPV vaccinations. Under the coordinated model, the clinic identified patients needing HPV vaccination(s), administered the first dose and described the option to complete the vaccination series at the pharmacy. Interested patients then had an information sheet faxed and electronic prescriptions sent to the pharmacy. The pharmacy contacted the patients to schedule administration of 2nd and 3rd doses of the HPV vaccine. Over a 12-month period, 51 patients were referred to the pharmacy by the clinic. Of these, 23 patients received a total of 25 vaccinations. Clinic and pharmacy personnel mostly rated the coordinated program favorably. An initial study of a coordinated HPV vaccination program between a medical clinic and a community pharmacy supported patients getting HPV vaccinations.

Sexual and reproductive health services provided by community pharmacists: a scoping review

“…62 Three studies targeted adolescents and/or younger adults, 58 61 62 one targeted individuals between 9 and 26 years old filling Open access acne or birth control prescriptions at the pharmacy, 60 and one did not specify the target group (online supplemental file 3). 59 HPV vaccination service was offered directly through the pharmacy, 58 60-62 or by a health clinic that promoted a community pharmacy as an alternate setting to complete the vaccination series. 59 Regarding service promotion, different strategies were described.…”

“…59 HPV vaccination service was offered directly through the pharmacy, 58 60-62 or by a health clinic that promoted a community pharmacy as an alternate setting to complete the vaccination series. 59 Regarding service promotion, different strategies were described. Calo et al included direct mailing to families with eligible children, radio and newspaper advertisements, posting fliers and promotion in the pharmacy using posters, bag stuffers, handouts, roadside signs and direct patient approach.…”

“…58 Other authors described similar strategies, with direct patient approach most commonly used. [59][60][61][62] There were, however, important barriers reported in these studies. In some states in the USA, community pharmacies are not included as qualified vaccine provider sites for vaccinating age-eligible adolescents.…”

Availability of the HPV Vaccine in Regional Pharmacies and Provider Perceptions Regarding HPV Vaccination in the Pharmacy Setting

“…A recent study by Douchette et al (2019) described a coordinated delivery of an HPV vaccine program using a clinic–pharmacy partnership. In their study, less than 50% of patients referred to a pharmacy received an HPV vaccine [ 25 ]. However, 100% of the patients that received the HPV vaccine in the pharmacy setting, after referral to the pharmacy for vaccination, completed the series.…”

Long Noncoding RNA KCNMB2-AS1 Stabilized by N6-Methyladenosine Modification Promotes Cervical Cancer Growth Through Acting as a Competing Endogenous RNA

“…Cervical cancer (CC) is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer-associated death among women worldwide, which has become a huge economic burden, especially in many underdeveloped countries 1 . Over the last few decades, despite many drugs or vaccines have been developed to antagonize CC, such as human papillomavirus (HPV) vaccination programs 2 , 3 , the 5-year survival rate is still not optimistic, especially for high-risk cases 4 . Therefore, continued dissection into mechanisms governing CC progression may yield promising therapeutic insights.…”